MétaCan
Menu
Back to cohort
Record W4328025794 · doi:10.1055/s-0042-1760055

Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset

2023· article· en· W4328025794 on OpenAlexaff
Alessandra Mangia, S. Fagiuoli, V. Di Marco, Stephen Shafran, Mandana Khalili, Scott Milligan, George Papatheodoridis, Denis Ouzan, Silvia Rosati, Alnoor Ramji, Elisabetta Teti, Montserrat Garcı́a-Retortillo, F. Gonzalvo Hernandez, Alexander Wong, Chris Fraser, Sergio Rodríguez‐Tajes, ElenaJimenèz Mutiloa, LuisEnriqueMorano Amado, Joss O’Loan, Francesca Campanale, Guilherme Macedo, Michele Stanislaw Milella, Christian Brixko, Marı́a Buti, MariaGuerra Veloz, Roberto Ranieri, Sergio Borgia, Annalisa Bascia, Lisa Baganz, ConradoManuelFernandez Rodriguez, Brian Conway, Victor de Lédinghen, Mary Fenech, Pablo Ryan, Ivana Maida, Alexandra Martins, Stacey Scherbakovsky, Ιωάννα Ντάλλα, Cándido Hernández, Kim Vanstraelen, Juan Turnés

Bibliographic record

VenueZeitschrift für Gastroenterologie · 2023
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsVancouver Infectious Diseases CentreUniversity of ReginaUniversity of British ColumbiaSaskatchewan Science CentreWilliam Osler Health SystemCommunity Based Research CentreUniversity of SaskatchewanUniversity of Alberta
Fundersnot available
KeywordsSofosbuvirMultinational corporationReal world dataMedicineVirologyIntensive care medicineBusinessComputer scienceData scienceHepatitis C virusRibavirinVirusFinance

Abstract

fetched live from OpenAlex

Background and Aims More HCV-patients (pts) being started on direct-acting antivirals (DAAs) are belonging to vulnerable populations. This real-world analysis describes the profiles of these populations. Method HCV-pts (18+years [y]) from 37 clinical cohorts across nine countries treated with SOF/VEL for 12 weeks without ribavirin were included. Those with a history of decompensation or prior NS5A-inhibitor exposure were excluded. This descriptive analysis evaluated patient characteristics, time to treatment (TT [time from HCV-RNA diagnosis to DAA-initiation]), and sustained virological response≥12 weeks after end of treatment (SVR), stratified by age and sex. Results Among 6356 pts, 2274 were aged<50y, 2568: 50−65y, and 1514>65y. The percentage of male was decreasing with age. Approx. 20% of all pts had past IV drug use. Irrespective of age, male pts were more likely to have compensated cirrhosis and HCV genotype (GT) 3 infection. Results in vulnerable male patients: Higher likelihood of incarceration in age-group≤65y, significantly fewer mental health disorders and median TT was shorter.. Use of antipsychotics appeared similar, irrespective of sex.. In 5845 pts with valid result, SVR was high across age ranges, independent of sex (<50y: female 98.7%, male 99.2%; 50−65y: female 98.7%, male 98.1%;>65y: female 99.3%, male 98.3%). 475 pts did not achieve SVR for a non-virological reason; mostly loss to follow-up, independent of gender. Conclusion Independent of gender, SOF/VEL results in high SVR rates. Significantly fewer mental health disorders were observed in male pts and TT was shorter. Publication History Article published online: 18 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.029
Threshold uncertainty score0.058

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.043
GPT teacher head0.353
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueZeitschrift für GastroenterologieSame topicHepatitis C virus researchFrench-language works237,207